Background: Despite significant public health advancements in prevention, screening and treatment of tuberculosis (TB), mortality with TB remains unacceptably high. The epidemiology of TB mortality is not well understood, and therefore urgent investigation of potentially modifiable aspects of TB care that could inform public health service delivery and improve patient outcomes is needed. The primary aim of this study was to evaluate the relationship between supervision of TB treatment and risk of TB death during TB treatment.Methods: A retrospective cohort study was conducted to estimate the effect of health provider supervision on the risk of all-cause TB mortality during TB treatment among clinically and/or laboratory verified active TB ...
INTRODUCTION:Tuberculosis (TB) requires at least six months of multidrug treatment and necessitates ...
Mortality among patients who complete tuberculosis (TB) treatment is still high among vulnerable pop...
OBJECTIVES:Mortality from tuberculosis (TB) has been declining since 2000, nevertheless there is sti...
BACKGROUND. Death from all causes during tuberculosis (TB) treatment has remained about 10% in San F...
BackgroundIdentifying those at increased risk of death during TB treatment is a priority in resource...
BackgroundTuberculosis is a leading cause of death worldwide, yet the determinants of death are not ...
Abstract Background Tuberculosis is a leading cause of death worldwide, yet the determinants of deat...
Rationale:More information on risk factors for death from tuberculosis in the United States could he...
Background: Mortality from tuberculosis (TB) remains high despite its declining global incidence. Ho...
INTRODUCTION: Mortality from tuberculosis, which should be a rare event, still affects a large porti...
Tuberculosis (TB) requires at least six months of multidrug treatment and necessitates monitoring fo...
BackgroundGlobally in 2016, 1.7 million people died of Tuberculosis (TB). This study aimed to estima...
Background: Mortality among patients who complete tuberculosis (TB) treatment is still high among vu...
To describe the molecular epidemiology of tuberculosis (TB)-related deaths in a well-managed program...
BACKGROUND: Despite effective anti-tuberculosis chemotherapy, case-fatality rates of up to 25% are d...
INTRODUCTION:Tuberculosis (TB) requires at least six months of multidrug treatment and necessitates ...
Mortality among patients who complete tuberculosis (TB) treatment is still high among vulnerable pop...
OBJECTIVES:Mortality from tuberculosis (TB) has been declining since 2000, nevertheless there is sti...
BACKGROUND. Death from all causes during tuberculosis (TB) treatment has remained about 10% in San F...
BackgroundIdentifying those at increased risk of death during TB treatment is a priority in resource...
BackgroundTuberculosis is a leading cause of death worldwide, yet the determinants of death are not ...
Abstract Background Tuberculosis is a leading cause of death worldwide, yet the determinants of deat...
Rationale:More information on risk factors for death from tuberculosis in the United States could he...
Background: Mortality from tuberculosis (TB) remains high despite its declining global incidence. Ho...
INTRODUCTION: Mortality from tuberculosis, which should be a rare event, still affects a large porti...
Tuberculosis (TB) requires at least six months of multidrug treatment and necessitates monitoring fo...
BackgroundGlobally in 2016, 1.7 million people died of Tuberculosis (TB). This study aimed to estima...
Background: Mortality among patients who complete tuberculosis (TB) treatment is still high among vu...
To describe the molecular epidemiology of tuberculosis (TB)-related deaths in a well-managed program...
BACKGROUND: Despite effective anti-tuberculosis chemotherapy, case-fatality rates of up to 25% are d...
INTRODUCTION:Tuberculosis (TB) requires at least six months of multidrug treatment and necessitates ...
Mortality among patients who complete tuberculosis (TB) treatment is still high among vulnerable pop...
OBJECTIVES:Mortality from tuberculosis (TB) has been declining since 2000, nevertheless there is sti...